House Oversight Committee Members Comer, McClain Probe Shortages of Schedule II Drugs, Including Adderall
May 15, 2024
May 15, 2024
WASHINGTON, May 15 -- Rep. James Comer, R-Kentucky, chairman of the House Oversight and Accountability Committee, issued the following news release:
House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) are furthering their investigation into the growing number of critical drug shortages impacting Americans' medical care. In a letter to Drug Enforcement Administration (DEA . . .
House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) and Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) are furthering their investigation into the growing number of critical drug shortages impacting Americans' medical care. In a letter to Drug Enforcement Administration (DEA . . .